Skip to main content

Table 1 Baseline data for Type 2 diabetes and control plasma LDL donors

From: Low density lipoprotein from patients with Type 2 diabetes increases expression of monocyte matrix metalloproteinase and ADAM metalloproteinase genes

 

TYPE 2 DIABETES

CONTROLS

p

Number

5

4

 

Age [yrs]

63.6 [0.93]

53.0 [3.08]

0.02

Known Diabetes duration [yrs]

7.8 [0.66]

-

 

M:F

02:03

02:02

 

Body Mass Index [kg/m 2 ]

30.2 [1.66]

25.5 [0.5]

ns

Waist – hip ratio

0.88 [0.02]

0.78 [0.05]

ns

Diabetes treatment

 

-

 

   Diet

1

  

   Sulphonylurea

2

  

   Metformin

1

  

   Sulphonylurea/metformin

1

  

HbA1c [%]

6.82 [0.56]

5.10 [0.10]

ns

Total cholesterol [mmol/l]

6.68 [0.55]

6.33 [0.70]

ns

LDL cholesterol [mmol/l]

4.30 [0.59]

4.4 [0.67]

ns

Triglycerides [mmol/l]

2.56 [0.31]

1.39 [0.08]

0.036

HDL cholesterol [mmol/l]

1.22 [0.08]

1.32 [0.05]

ns

  1. Data shown as mean and [standard error of mean] ns = not significant.